{
    "Title": "Rationalizing the design of a broad coverage Shigella vaccine based on evaluation of immunological cross-reactivity among S. flexneri serotypes",
    "URL": "https://doi.org/10.1371/journal.pntd.0009826",
    "Published": "October 13, 2021",
    "Subject_Areas": [
        "Shigella flexneri",
        "Immune serum",
        "Antibodies",
        "Cross reactivity",
        "Shigella",
        "Vaccines",
        "Vaccine development",
        "Antigens"
    ],
    "Authors": {
        "Francesco Citiulo": [
            "GSK Vaccines Institute for Global Health S.r.l. (GVGH), Siena, Italy"
        ],
        "Francesca Necchi": [
            "GSK Vaccines Institute for Global Health S.r.l. (GVGH), Siena, Italy"
        ],
        "Francesca Mancini": [
            "GSK Vaccines Institute for Global Health S.r.l. (GVGH), Siena, Italy"
        ],
        "Omar Rossi": [
            "GSK Vaccines Institute for Global Health S.r.l. (GVGH), Siena, Italy"
        ],
        "Maria Grazia Aruta": [
            "GSK Vaccines Institute for Global Health S.r.l. (GVGH), Siena, Italy"
        ],
        "Gianmarco Gasperini": [
            "GSK Vaccines Institute for Global Health S.r.l. (GVGH), Siena, Italy"
        ],
        "Renzo Alfini": [
            "GSK Vaccines Institute for Global Health S.r.l. (GVGH), Siena, Italy"
        ],
        "Simona Rondini": [
            "GSK, Siena, Italy"
        ],
        "Francesca Micoli": [
            "GSK Vaccines Institute for Global Health S.r.l. (GVGH), Siena, Italy"
        ],
        "Rino Rappuoli": [
            "GSK, Siena, Italy"
        ],
        "Allan Saul": [
            "GSK Vaccines Institute for Global Health S.r.l. (GVGH), Siena, Italy"
        ],
        "Laura B. Martin": [
            "GSK Vaccines Institute for Global Health S.r.l. (GVGH), Siena, Italy"
        ]
    }
}